Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahir Patel

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Expert Opinion on Biological Therapy|October 29, 2013
Biological therapies for psoriasisBobbak Mansouri, Mahir Patel, Alan Menter
Proceedings (Baylor University. Medical Center)|January 26, 2012
Secondary syphilis and HIVShagun Dhaliwal, Mahir Patel, Alan Menter
Proceedings (Baylor University. Medical Center)|April 7, 2012
Widespread dermal ulcerations and bullaeJay Wofford, Mahir Patel, Allison Readinger, et al.
Expert Opinion on Investigational Drugs|March 10, 2012
Current investigational drugs in psoriasisCaitriona Ryan, Amanda Abramson, Mahir Patel, et al.
Proceedings (Baylor University. Medical Center)|December 9, 2014
Angiolymphoid hyperplasia with eosinophiliaPrathyusha Chitrapu, Mahir Patel, Allison Readinger, et al.
Journal of Drugs in Dermatology : JDD|August 14, 2014
Ustekinumab treatment for psoriasis in 119 patients maintained on therapy for a minimum of one year: a reviewElizabeth G Wilder, Mahir Patel, Katherine Hebeler, et al.
Dermatology and Therapy|December 4, 2012
Emerging therapies for the treatment of psoriasisMahir Patel, Antoinette Day, Richard B Warren, et al.
Proceedings (Baylor University. Medical Center)|January 2, 2016
Disseminated cutaneous histoplasmosis in newly diagnosed HIVGabriela M Soza, Mahir Patel, Allison Readinger, et al.
Journal of Drugs in Dermatology : JDD|June 12, 2014
A retrospective analysis of 72 patients on prior efalizumab subsequent to the time of voluntary market withdrawal in 2009Elizabeth Farley Prater, Antoinette Day, Mahir Patel, et al.
Expert Opinion on Emerging Drugs|November 27, 2013
Emerging topical treatments for psoriasisDario N Kivelevitch, Katherine R Hebeler, Mahir Patel, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Expert Opinion on Biological Therapy|October 29, 2013
Biological therapies for psoriasisBobbak Mansouri, Mahir Patel, Alan Menter
Proceedings (Baylor University. Medical Center)|January 26, 2012
Secondary syphilis and HIVShagun Dhaliwal, Mahir Patel, Alan Menter
Proceedings (Baylor University. Medical Center)|April 7, 2012
Widespread dermal ulcerations and bullaeJay Wofford, Mahir Patel, Allison Readinger, et al.
Expert Opinion on Investigational Drugs|March 10, 2012
Current investigational drugs in psoriasisCaitriona Ryan, Amanda Abramson, Mahir Patel, et al.
Proceedings (Baylor University. Medical Center)|December 9, 2014
Angiolymphoid hyperplasia with eosinophiliaPrathyusha Chitrapu, Mahir Patel, Allison Readinger, et al.
Journal of Drugs in Dermatology : JDD|August 14, 2014
Ustekinumab treatment for psoriasis in 119 patients maintained on therapy for a minimum of one year: a reviewElizabeth G Wilder, Mahir Patel, Katherine Hebeler, et al.
Dermatology and Therapy|December 4, 2012
Emerging therapies for the treatment of psoriasisMahir Patel, Antoinette Day, Richard B Warren, et al.
Proceedings (Baylor University. Medical Center)|January 2, 2016
Disseminated cutaneous histoplasmosis in newly diagnosed HIVGabriela M Soza, Mahir Patel, Allison Readinger, et al.
Journal of Drugs in Dermatology : JDD|June 12, 2014
A retrospective analysis of 72 patients on prior efalizumab subsequent to the time of voluntary market withdrawal in 2009Elizabeth Farley Prater, Antoinette Day, Mahir Patel, et al.
Expert Opinion on Emerging Drugs|November 27, 2013
Emerging topical treatments for psoriasisDario N Kivelevitch, Katherine R Hebeler, Mahir Patel, et al.
Pageof 3